Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Brian Winters

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
The Prostate|July 24, 2015
Metformin effects on biochemical recurrence and metabolic signaling in the prostateBrian Winters, Stephen Plymate, Steven B Zeliadt, et al.
Clinical Genitourinary Cancer|January 29, 2023
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder CancerDimitrios Makrakis, Jonathan L Wright, Martine P Roudier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Ewan A Gibb, Natalie Q Wang, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|April 13, 2019
2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly QuestionsEdward M Schwarz, Javad Parvizi, Thorsten Gehrke, et al.
European Urology|April 10, 2017
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Hussam Al Deen Ashab, Nicholas Erho, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
The Prostate|July 24, 2015
Metformin effects on biochemical recurrence and metabolic signaling in the prostateBrian Winters, Stephen Plymate, Steven B Zeliadt, et al.
Clinical Genitourinary Cancer|January 29, 2023
A Phase 1/2 Study of Rapamycin and Cisplatin/Gemcitabine for Treatment of Patients With Muscle-Invasive Bladder CancerDimitrios Makrakis, Jonathan L Wright, Martine P Roudier, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 19, 2018
Divergent Biological Response to Neoadjuvant Chemotherapy in Muscle-invasive Bladder CancerRoland Seiler, Ewan A Gibb, Natalie Q Wang, et al.
Journal of Orthopaedic Research : Official Publication of the Orthopaedic Research Society|April 13, 2019
2018 International Consensus Meeting on Musculoskeletal Infection: Research Priorities from the General Assembly QuestionsEdward M Schwarz, Javad Parvizi, Thorsten Gehrke, et al.
European Urology|April 10, 2017
Impact of Molecular Subtypes in Muscle-invasive Bladder Cancer on Predicting Response and Survival after Neoadjuvant ChemotherapyRoland Seiler, Hussam Al Deen Ashab, Nicholas Erho, et al.
Pageof 2